News

A new study found that girls between 9 and 14 years of age who received a two-dose HPV-16/18 AS04-adjuvanted vaccine over a 6 or 12-month period of time are just as protected from HPV as girls between 15 and 25 years of age who received a three-dose vaccine over the course of 6 months.

The first household survey was conducted in Liberia to examine the collateral harm to maternal healthcare delivery services in areas impacted by the Ebola epidemic. It showed that since the Ebola epidemic began, facility-based deliveries have declined mostly due to fear of acquiring infection, keeping women away from using the healthcare services available to them.

Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.